Literature DB >> 25676442

Prediction of Voriconazole Non-linear Pharmacokinetics Using a Paediatric Physiologically Based Pharmacokinetic Modelling Approach.

Trevor N Johnson1, Farzaneh Salem, Masoud Jamei, Amin Rostami-Hodjegan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25676442     DOI： 10.1007/s40262-015-0247-5

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  9 in total

1.  Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues.

Authors:  Yasuhiro Miki; Takashi Suzuki; Chika Tazawa; Bruce Blumberg; Hironobu Sasano
Journal:  Mol Cell Endocrinol       Date:  2005-01-23       Impact factor: 4.102

2.  Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age.

Authors:  May Fakhoury; Catherine Litalien; Yves Medard; Hélène Cavé; Nadia Ezzahir; Michel Peuchmaur; Evelyne Jacqz-Aigrain
Journal:  Drug Metab Dispos       Date:  2005-07-27       Impact factor: 3.922

3.  A re-evaluation and validation of ontogeny functions for cytochrome P450 1A2 and 3A4 based on in vivo data.

Authors:  Farzaneh Salem; Trevor N Johnson; Khaled Abduljalil; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

4.  Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis.

Authors:  T N Johnson; M S Tanner; C J Taylor; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

5.  Pharmacokinetics and metabolism of oral midazolam in preterm infants.

Authors:  S N de Wildt; G L Kearns; W C J Hop; D J Murry; S M Abdel-Rahman; J N van den Anker
Journal:  Br J Clin Pharmacol       Date:  2002-04       Impact factor: 4.335

6.  Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.

Authors:  Mats O Karlsson; Irja Lutsar; Peter A Milligan
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3.

Authors:  Souzan B Yanni; Pieter P Annaert; Patrick Augustijns; Joseph G Ibrahim; Daniel K Benjamin; Dhiren R Thakker
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

8.  Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.

Authors:  R Hyland; B C Jones; D A Smith
Journal:  Drug Metab Dispos       Date:  2003-05       Impact factor: 3.922

9.  A physiologically based pharmacokinetic model for voriconazole disposition predicts intestinal first-pass metabolism in children.

Authors:  Nicole R Zane; Dhiren R Thakker
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447
  9 in total
  3 in total

1.  Response to: "Prediction of Voriconazole Non-Linear Pharmacokinetics Using a Paediatric Physiologically Based Pharmacokinetic Modelling Approach".

Authors:  Nicole R Zane; Dhiren R Thakker
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

Review 2.  Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.

Authors:  Frederique Rodieux; Melanie Wilbaux; Johannes N van den Anker; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

Review 3.  Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.

Authors:  Jean-Marie Nicolas; François Bouzom; Chanteux Hugues; Anna-Lena Ungell
Journal:  Biopharm Drug Dispos       Date:  2017-02-06       Impact factor: 1.627
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.